| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/28/2013 | CN103263439A CD34 stem cell-related methods and compositions |
| 08/28/2013 | CN103263433A Medical application of natural product 6-shogaol in enhancing chemosensitivity of pancreatic cancer on gemcitabine and compound drug composite of natural product 6-shogaol |
| 08/28/2013 | CN103263431A Application of polyflavanostilbene A in preparation of medicaments for treating tongue carcinoma |
| 08/28/2013 | CN103263430A Application of polyflavanostilbene A in preparation of medicaments for treating lung cancer |
| 08/28/2013 | CN103263429A Application of polyflavanostilbene A in preparation of medicaments for treating cervical cancer |
| 08/28/2013 | CN103263420A Application of myriberine A in preparation of medicaments for treating tongue carcinoma |
| 08/28/2013 | CN103263417A Itraconazole isomer and medical application thereof |
| 08/28/2013 | CN103263416A Application of pyridylamine compound in preparation of drugs used for treating lung cancer and suitable for oral administration |
| 08/28/2013 | CN103263414A Application of 2,2'-(1,4-phenylene)di(benzimidazole-5-carboxylic acid) in preparation of antitumor drug |
| 08/28/2013 | CN103263409A Application of bixanthone compound FLBG-1108 or its pharmaceutical salts in preparation of anti-cancer drugs |
| 08/28/2013 | CN103263408A Allicin nano liposome and preparation method and application thereof |
| 08/28/2013 | CN103263403A Application of borneol in preparation of drug used for inhibiting tumorigenesis |
| 08/28/2013 | CN103263393A Ardipusilloside I slow-release implant tablets and preparation method thereof |
| 08/28/2013 | CN103263392A Amoitone derivative long-circulation nanometer lipid carrier and preparation method thereof |
| 08/28/2013 | CN103263390A Sorafenib nano particle and application thereof |
| 08/28/2013 | CN103263388A Folic acid modified norcantharidin stealth niosome and preparation method thereof |
| 08/28/2013 | CN102872144B Application of Houttuynoid D in drug for treating bladder cancer |
| 08/28/2013 | CN102872125B Application of Houttuynoid C in medicament for treating cervical cancer |
| 08/28/2013 | CN102872113B Application of Houttuynoid A in medicament for treating leukemia |
| 08/28/2013 | CN102872110B Application of Houttuynoid D in medicament for treating breast cancer |
| 08/28/2013 | CN102872093B Application of Houttuynoid E in medicine for treating pancreatic cancer |
| 08/28/2013 | CN102872077B Application of Houttuynoid B in drugs for treating endometrial cancer |
| 08/28/2013 | CN102872070B Application of Houttuynoid C to preparing drugs for treating prostate cancer |
| 08/28/2013 | CN102861093B Application of Houttuynoid B in medicine for treating colorectal cancer |
| 08/28/2013 | CN102861089B Application of Houttuynoid B in medicine for treating liver cancer |
| 08/28/2013 | CN102861070B Application of Houttuynoid E in medicine for treating tongue cancer |
| 08/28/2013 | CN102861069B Application of Houttuynoid B in medicine for treating laryngocarcinoma |
| 08/28/2013 | CN102861065B Application of Houttuynoid E in medicine for treating gastric cancer |
| 08/28/2013 | CN102861058B Application of Houttuynoid D in cholangiocarcinoma treatment medicine |
| 08/28/2013 | CN102861056B Application of Houttuynoid A in endometrial cancer treatment medicine |
| 08/28/2013 | CN102861049B Application of Houttuynoid A in medicine for treating liver cancer |
| 08/28/2013 | CN102796072B Alizarin dioxane derivatives, and preparation method and application thereof |
| 08/28/2013 | CN102764274B Method for extracting propolis |
| 08/28/2013 | CN102727854B Traditional Chinese medicine for treatment of gastric cancer |
| 08/28/2013 | CN102688460B Medicine combination for preventing or treating liver cancer |
| 08/28/2013 | CN102641243B 7-ethyl-10-hydroxycamptothecine liposome for injection and preparing method thereof |
| 08/28/2013 | CN102604083B Polymer modified lipid material and application thereof |
| 08/28/2013 | CN102603909B Laminarin with antioxidation and antineoplastic activity and extracting-separating method of laminarin |
| 08/28/2013 | CN102579502B Toxic-free method for separating shuck of eupolyphaga egg from internal egg |
| 08/28/2013 | CN102552847B Ginger and inula flower composition for reducing vomiting caused by cancer chemotherapy and increasing curative effect for chemotherapy and preparing method thereof |
| 08/28/2013 | CN102552142B Liposome preparing method suitable for industrial production |
| 08/28/2013 | CN102526020B Application of oridonin in preparing activator of tumor-suppressor protein FBW7 |
| 08/28/2013 | CN102512452B Process method for preparing sea cucumber glycosides by using sea cucumber coelomic fluid |
| 08/28/2013 | CN102503882B Halogenated benzaldehyde indole Schiff base as well as preparation method and application thereof |
| 08/28/2013 | CN102492051B Polygonatum odoratum deep processing and comprehensive utilization process |
| 08/28/2013 | CN102470133B Quinoline derivative-containing pharmaceutical composition |
| 08/28/2013 | CN102451216B Application of anthocyanidin extract in inhibition of PKC-alpha activation and NF-kappaB activation |
| 08/28/2013 | CN102389430B Application of small molecular compounds to preparation of anti-lung-cancer medicine |
| 08/28/2013 | CN102379850B Targeted administration liposome passing through mucus barriers of human bodies |
| 08/28/2013 | CN102302529B Purple ginseng prepared by vaccinium fermentation method and application thereof in medicine |
| 08/28/2013 | CN102302477B Cinobufagin dry power inhaler and preparation method and application thereof |
| 08/28/2013 | CN102277330B Human CD3+CD8+gamma delta T lymphocyte, as well as preparation method and application thereof |
| 08/28/2013 | CN102276612B C-2 substituted Aldisin derivative and medicinal salt thereof, their pharmaceutical composition, and application in preparation of antitumor drug thereof |
| 08/28/2013 | CN102266370B Semi-bionic extraction method for anti-stomach-cancer active substance in Hangzhou white chrysanthemum |
| 08/28/2013 | CN102260293B Transition metal coordination compounds with oxoglaucine as ligand, synthesizing method thereof, and application thereof |
| 08/28/2013 | CN102260281B Oxidized glaucine rare earth chelate compound as well as synthesis method and application thereof |
| 08/28/2013 | CN102250202B 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof |
| 08/28/2013 | CN102241693B N,N'-di-(1-methyl-beta-carboline-3-formyl)-lysly aminoacid benzyl esters, synthetic method thereof and application thereof |
| 08/28/2013 | CN102204951B Method for extracting active components from licorice |
| 08/28/2013 | CN102190625B Stilbene tumor targeted medicine Combretastatin A4 analogs |
| 08/28/2013 | CN102140473B Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/28/2013 | CN102137860B Pyrimidines composition and method for preparing same |
| 08/28/2013 | CN102123986B Pharmaceutical compositions |
| 08/28/2013 | CN102083424B Methods and use of inducing apoptosis in cancer cells |
| 08/28/2013 | CN102070726B Method for safely extracting cordyceps sinensis polysaccharide |
| 08/28/2013 | CN102015681B Crystal form of phenylamino pyrimidine derivatives |
| 08/28/2013 | CN101982464B Annonaceous acetogenin compound and synthesis method and application thereof |
| 08/28/2013 | CN101935317B Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof |
| 08/28/2013 | CN101906148B Survivin-derived peptides and use thereof |
| 08/28/2013 | CN101870689B 3-(1-halogenated methylene) sulphur chromane-4-ketone compound as well as preparation method and application thereof |
| 08/28/2013 | CN101830819B Phenylbutyryl curcumin derivate and application thereof in anti-tumor drug preparation |
| 08/28/2013 | CN101535276B Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors |
| 08/28/2013 | CN101489575B FKBP-L and uses thereof |
| 08/28/2013 | CN101432281B 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 08/28/2013 | CN101273977B Preparation technique of tryptanthrin preparations and uses thereof |
| 08/28/2013 | CN101194017B Conjugate comprising P21 protein for the treatment of cancer |
| 08/27/2013 | US8519129 Pyrimidine derivatives as kinase inhibitors |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518965 Compositions and methods for treating cancer |
| 08/27/2013 | US8518936 Method for preparing acid addition salts of polyacidic basic compounds |
| 08/27/2013 | US8518931 Compounds and compositions as kinase inhibitors |
| 08/27/2013 | US8518897 Method of treatment for cancers associated with elevated HER2 levels |
| 08/27/2013 | US8518896 Treatment of cancers of the blood using selected glycomimetic compounds |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518889 Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2 |
| 08/27/2013 | US8518887 Method of treating cancer with DLL4 antagonist and chemotherapeutic agent |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518442 Prolonged release bioadhesive therapeutic systems |
| 08/27/2013 | US8518388 Cyclodextrin-based polymers for therapeutics delivery |
| 08/27/2013 | CA2777473C Compounds and methods for the treatment of cancer |
| 08/27/2013 | CA2678754C Process for the preparation and purification of thiol-containing maytansinoids |
| 08/27/2013 | CA2566315C Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumour cells |
| 08/27/2013 | CA2531868C Process for the preparation of thalidomide |
| 08/27/2013 | CA2526212C Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 08/27/2013 | CA2486918C Novel chimeric cd154 |
| 08/27/2013 | CA2462675C Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |